Meeting Professionals International (MPI)
MPI Announces Istanbul Türkiye as the Host City for EMEC 2025
MPI Announces Istanbul Türkiye as the Host City for EMEC 2025
European Meetings & Events Conference Returns to Türkiye for the First Time Since 2014
Dallas, Texas, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Dallas, TX – 26 September, 2024: Meeting Professionals International (MPI), the world’s largest Meetings, Incentives, Conferences and Exhibitions (MICE) association with a global community of 140,000 professionals and membership of 13,000, is excited to announce that its 2025 European Meetings & Events Conference (EMEC) will take place in Istanbul, Türkiye, from 22-25 February, 2025.
The dynamic city, known for its rich history, culture and unique position bridging Europe and Asia, will once again serve as a vibrant backdrop for the global meetings and events community. The last time EMEC was held in Istanbul was in 2014, and this return marks a significant moment for both MPI and its host. Registration for EMEC Türkiye officially went live on 26 September, 2024, at mpi.org/emec.
In addition to serving as the largest global MICE association, MPI also boasts the industry’s largest EMEA presence with 1,000 members and 10 Chapters and Clubs. Now in its 37th year, EMEC brings together 300-400 global MICE professionals within a format that has received multiple awards, including recognition by BEA and a Gouden Giraffe.
Paul Van Deventer, President and CEO of MPI, emphasized the importance of this return to Istanbul, commenting that “EMEC has long been a cornerstone for the global events community, fostering professional development through innovation, learning and connections. Returning to Istanbul after more than a decade is not only a testament to the city’s enduring appeal but also a clear indicator of the excitement and popularity surrounding this iconic destination. Istanbul offers a unique blend of tradition and modernity that resonates with our international audience, and we are thrilled to bring EMEC back to this vibrant city.”
EMEC is designed with three primary tenets at its core: to serve as an idea incubator for the global MICE community, designed by Europeans for Europeans and to carry a strong reflection of the host destination – its culture, history and heritage.
İsmail Bütün, General Manager of the Türkiye Tourism Promotion and Development Agency (TGA) echoed Van Deventer’s sentiments, underscoring the impact EMEC will have on their global MICE presence. “Hosting EMEC 2025 is a monumental opportunity for Türkiye to showcase its position on the global MICE stage. Istanbul has a proven track record of hosting large-scale international events, and EMEC’s return highlights our commitment to growing and evolving as a premier destination for meetings and events professionals.”
As MPI continues to expand the reach of EMEC, the organization is also pleased to announce that it will soon be releasing a request for proposals (RFP) for the 2026 and 2027 host destinations. With the bar set high for EMEC Türkiye in 2025, MPI invites destinations from around EMEA to apply and showcase their ability to host this prestigious conference.
For more information, visit www.mpi.org/emec.
About MPI
Meeting Professionals International (MPI) is the largest meeting and event industry association worldwide. The organization provides innovative and relevant education, networking opportunities and business exchanges, and acts as a prominent voice for the promotion and growth of the industry. MPI has a global community of 140,000 engaged meeting and event professionals including nearly 13,000 members. It has It has nearly 70 chapters, clubs and members in more than 75 countries worldwide. “When we meet, we change the world.” www.mpi.org
Attachment
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
F. Hoffmann-La Roche Ltd8.12.2024 18:30:00 CET | Press release
Five-year results confirm Roche’s Polivy combination therapy as new standard of care for previously untreated aggressive lymphoma
Novartis Pharma AG8.12.2024 18:30:00 CET | Press release
Longer-term data for Novartis Scemblix® reinforce superior efficacy with favorable safety and tolerability profile in adults with newly diagnosed CML
Genmab A/S8.12.2024 17:00:00 CET | Press release
Investigational Epcoritamab (DuoBody® CD3xCD20) Monotherapy Achieves High Overall and Complete Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) in Preliminary Analysis
Genmab A/S8.12.2024 01:12:00 CET | Press release
Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Demonstrates High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
Galapagos NV7.12.2024 18:30:00 CET | Press release
Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom